The Working Group participants
| Role | Name | Title | Organisation |
|---|---|---|---|
| Chair | Lord John Selborne KBE FRS | ||
| Royal Society | Dr Nick Green | Team Leader, (Biosciences, Int Security & New & Emerging Tech) | Royal Society |
| Insight Investment | Ms Rachel Crossley | Director, Investor Responsibility | Insight Investment |
| NIA | Dr Steffi Friedrichs | Director | NIA |
| Nanotechnology KTN | Dr Mike Pitkethly | CEO | Nanotechnology KTN |
| Secretariat | Ms Hilary Sutcliffe | Director | |
| Business | Mr Chris Wilson | External Communications Manager | BASF |
Dr Charles-Francois Gaudefroy |
Head of Technical Affairs |
Unilever |
|
| Dr Benjamin Gannon |
Exec Director Gov Affairs – EU |
Johnson & Johnson |
|
| Dr Russell Clarke | Commercial Manager | Thomas Swan | |
| Dr Barry Park | COO | Oxonica | |
| Dr Peter Bishop (Dr Sally Jones) |
Research Manager (Public Relations Manager) |
Johnson Matthey |
|
| Dr Anthony Dagger Dr Graeme Howling |
Research Scientist Project Manager - Biomaterials |
Smith & Nephew |
|
| Stuart Challenor (Ms Deborah Hayeems) |
Trading Law & Technical Mngr ( Corporate Governance Mngr) |
Tesco |
|
| Academic/Science | Dr Rob Aitken | Director of Research Development | Institute of Occupational Medicine |
| Prof Vicki Stone | Director of Toxicology | Napier Universityn Edinburgh | |
| Prof Richard Jones FRS | Prof of Physics | University of Sheffield | |
| Prof Nick Pidgeon | Prof of Applied Psychology | University of Cardiff | |
| NGO and other organisations | Ms Sue Davies | Chief Policy Advisor | Which? |
| Dr David Grimshaw | International Team Leader - Nanotechnologies | Practical Action | |
| Mr Frank Barry | Representative | Amicus | |